Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria
- 1 August 1993
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 105 (2) , 500-506
- https://doi.org/10.1016/0016-5085(93)90726-s
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Haem-arginate plus tin-protoporphyrin for acute hepatic porphyriaThe Lancet, 1991
- Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.Gut, 1990
- CONTROLLED TRIAL OF HAEM ARGINATE IN ACUTE HEPATIC PORPHYRIAThe Lancet, 1989
- Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyriaHepatology, 1989
- Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteersThe American Journal of Medicine, 1988
- Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjectsHepatology, 1988
- Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.Journal of Clinical Investigation, 1985
- Control of Heme Oxygenase and Plasma Levels of Bilirubin by a Synthetic Heme Analogue, Tin-ProtoporphyrinHepatology, 1984
- PREVENTION OF ACUTE PORPHYRIC ATTACKS BY INTRAVENOUS HÆMATINThe Lancet, 1978
- Induction of heme oxygenase by hemin in cultured pig alveolar macrophagesArchives of Biochemistry and Biophysics, 1978